Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
---|---|---|---|---|---|---|---|---|
Jul 30, 2025 | Jul 30, 2025 | Hansen Gwenn Chief Scientific Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $12.01 | $51,743 | -5.87% |
Apr 30, 2025 | Apr 30, 2025 | Hansen Gwenn Chief Scientific Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $11.5 | $38,841 | -5.20% |
Jan 30, 2025 | Jan 31, 2025 | Hansen Gwenn Chief Scientific Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $19.85 | $73,260 | -6.19% |
Oct 30, 2024 | Oct 31, 2024 | Hansen Gwenn Chief Scientific Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $24.31 | $83,536 | -6.35% |
Jul 30, 2024 | Jul 30, 2024 | Hansen Gwenn Chief Scientific Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $20.67 | $70,436 | -7.02% |
Apr 30, 2024 | Apr 30, 2024 | Hansen Gwenn Chief Scientific Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $12.04 | $24,169 | -4.82% |
Jan 30, 2024 | Jan 30, 2024 | Hansen Gwenn Chief Scientific Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $7.99 | $18,649 | -6.03% |
Oct 31, 2023 | Nov 01, 2023 | Hansen Gwenn Chief Scientific Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $5.2 | $8,487 | -4.64% |
Jul 31, 2023 | Aug 01, 2023 | Hansen Gwenn Chief Scientific Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $9.65 | $18,189 | -5.92% |
May 01, 2023 | May 02, 2023 | Hansen Gwenn Chief Scientific Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $9.88 | $11,219 | -4.09% |
Jan 30, 2023 | Feb 01, 2023 | Hansen Gwenn Chief Scientific Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $11.78 | $16,633 | -5.78% |
Oct 31, 2022 | Nov 01, 2022 | Hansen Gwenn Chief Scientific Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $12.88 | $15,006 | -5.21% |
Aug 01, 2022 | Aug 02, 2022 | Hansen Gwenn Chief Scientific Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $15.67 | $18,585 | -5.83% |
May 02, 2022 | May 03, 2022 | Hansen Gwenn Chief Scientific Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $11.75 | $12,902 | -6.02% |
Jan 03, 2022 | Jan 04, 2022 | Hansen Gwenn Chief Scientific Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $28.96 | $52,939 | -11.41% |
Dec 01, 2021 | Dec 02, 2021 | Hansen Gwenn Chief Scientific Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $29.13 | $11,652 | -2.74% |
Nov 01, 2021 | Nov 02, 2021 | Hansen Gwenn Chief Scientific Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $33.24 | $13,296 | -2.74% |
Oct 27, 2021 | Oct 28, 2021 | Hansen Gwenn Chief Scientific Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $35 | $14,000 | -2.74% |
Oct 01, 2021 | Oct 04, 2021 | Hansen Gwenn Chief Scientific Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $29.92 | $11,968 | -2.74% |
Sep 07, 2021 | Sep 08, 2021 | Hansen Gwenn Chief Scientific Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $35 | $56,000 | -10.13% |
Sep 01, 2021 | Sep 02, 2021 | Hansen Gwenn Chief Scientific Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $32.34 | $12,936 | -2.74% |
Aug 02, 2021 | Aug 03, 2021 | Hansen Gwenn Chief Scientific Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $31.21 | $12,484 | -2.82% |
Jul 01, 2021 | Jul 02, 2021 | Hansen Gwenn Chief Scientific Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $26.76 | $10,704 | -2.82% |
Jun 01, 2021 | Jun 02, 2021 | Hansen Gwenn Chief Scientific Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $27.74 | $11,096 | -2.82% |
May 03, 2021 | May 04, 2021 | Hansen Gwenn Chief Scientific Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $35 | $27,996 | -5.48% |
Apr 05, 2021 | Apr 06, 2021 | Hansen Gwenn Chief Scientific Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $35 | $14,000 | -2.82% |
Apr 01, 2021 | Apr 02, 2021 | Hansen Gwenn Chief Scientific Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $31.55 | $12,620 | -2.82% |
Mar 16, 2021 | Mar 16, 2021 | Hansen Gwenn Chief Scientific Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $45 | $36,000 | -5.48% |
Mar 01, 2021 | Mar 02, 2021 | Hansen Gwenn Chief Scientific Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $35.95 | $28,760 | -5.48% |
Feb 18, 2021 | Feb 22, 2021 | Hansen Gwenn Chief Scientific Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $36.27 | $29,018 | -6.25% |